News

News about advances made possible through IPIRA's work, such as innovations commercialized, campus partnerships with industry, and companies born out of licensing UC Berkeley intellectual property rights.

All News

July 17, 2023

Sanofi Taps Scribe for In Vivo Partnership Worth More Than $1.2B Biobucks Aimed at Sickle Cell and Beyond

https://www.fiercebiotech.com/biotech/sanofi-scribe-seal-new-vivo-partne...

Unlocking the Power of Advanced Sensor Technology: Calyx’s Breakthrough in Ammonia Monitoring for Poultry Farms

Link

July 7, 2023

Meet the Founder: Pow.bio’s Ouwei Wang on Why a Continuous Process Could Radically Change the Economics of Precision Fermentation

https://agfundernews.com/meet-the-founder-pow-bios-ouwei-wang-on-why-a-c...

July 6, 2023

Caribou Biosciences Announces $25 Million Equity Investment from Pfizer

https://investor.cariboubio.com/news-releases/news-release-details/carib...

June 15, 2023

Customcells Launches Development Partnership with OneD

https://customcells.com/customcells-launches-development-partnership-wit...

May 23, 2023

Tiger Global Backs Industrial IoT Startup Infinite Uptime in $18.8M Funding Round

https://techcrunch.com/2023/05/22/tiger-global-india-infinite-uptime-fun...

May 11, 2023

C. Light Receives Clearance for Retinal Eye Movement Monitor, Retitrack(TM)

https://www.accesswire.com/viewarticle.aspx?id=754350

May 2, 2023

Berkeley SkyDeck Joins UC Berkeley’s Life Sciences Entrepreneurship Center to Help Launch Berkeley Faculty-Led Startups: Asparaglue, EditPep, and MZR Neurotech

Link

May 1, 2023

Scribe Inks Up-to-$1.5B Partnership to Develop CRISPR-Based Medicines for Neurologic and Neuromuscular Diseases

https://www.businesswire.com/news/home/20230516005560/en/Scribe-Announce...

March 21, 2023

Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company

https://www.prnewswire.com/news-releases/berkeley-lights-completes-acqui...

March 20, 2023

Gilead Exercises Option to License Nurix’s IRAK4 Targeted Protein Degrader Development Candidate, NX-0479

Gilead Exercises Option to License Nurix’s IRAK4 Targeted Protein Degrader Development Candidate, NX-0479

December 20, 2022

Harnessing the Potential of Regenerative Stem Cell Secretomes in Age-related Disease

Link

November 12, 2022

Intellia Talks 'Functional Cure' for HAE with Interim Data for 2nd CRISPR Candidate

Link

November 8, 2022

Juvena Therapeutics Secures $41 Million to Accelerate the Discovery and Development of Biologics for Chronic and Age-Related Diseases

Link

November 1, 2022

Pittsburgh Knights Partners with Setex for eGame Thumbgrips with Gecko-inspired Anti-slip Technology

Link

October 19, 2022

Ambi Robotics Raises Funding for New Kind of Warehouse Robot

Link

October 5, 2022

Former Berkeley Professor and Startup Founder Carolyn Bertozzi Shares Chemistry Nobel Prize

Link

Valitor Raises $28M Series B Financing

Link

September 27, 2022

Sanofi and Jennifer Doudna-Founded Scribe Ink $1B CRISPR Cell Therapy Deal

Link

September 14, 2022

Cultured meat startup Prolific Machines unveils its ‘Henry Ford approach’ to cell growth

Link